We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+6.63%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$7.21B
AUM Growth
+$694M
Cap. Flow
+$299M
Cap. Flow %
4.15%
Top 10 Hldgs %
73.33%
Holding
137
New
11
Increased
44
Reduced
45
Closed
5

Top Buys

Rank Stock Value
1
KO icon
Coca-Cola
KO
+$296M
2
PG icon
Procter & Gamble
PG
+$109M
3
HDB icon
HDFC Bank
HDB
+$15.1M
4
MRK icon
Merck
MRK
+$7.64M
5
ALKS icon
Alkermes
ALKS
+$7.35M

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$77.1M
2
V icon
Visa
V
+$18.2M
3
HD icon
Home Depot
HD
+$9.27M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$9.07M
5
BIDU icon
Baidu
BIDU
+$7.1M

Sector Composition

Rank Sector Weight
1 Financials 29.05%
2 Consumer Discretionary 18.26%
3 Communication Services 15.15%
4 Healthcare 13.9%
5 Consumer Staples 10%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
26
Merck
MRK
$321B
$20M 0.28%
345,793
+135,337
+64% +$7.64M
PFE icon
27
Pfizer
PFE
$143B
$18.9M 0.26%
548,674
-30,371
-5% -$1.04M
GILD icon
28
Gilead Sciences
GILD
$165B
$17.4M 0.24%
245,983
-32,887
-12% -$2.32M
AGN
29
DELISTED
Allergan plc
AGN
$14.2M 0.2%
85,101
– –
BIIB icon
30
Biogen
BIIB
$30.9B
$14.1M 0.2%
48,586
– –
EW icon
31
Edwards Lifesciences
EW
$49.3B
$13.4M 0.19%
277,179
– –
SHPG
32
DELISTED
Shire pic
SHPG
$13.3M 0.18%
78,678
-935
-1% -$151K
ABBV icon
33
AbbVie
ABBV
$467B
$13.3M 0.18%
143,271
– –
BDX icon
34
Becton Dickinson
BDX
$46.4B
$12.7M 0.18%
54,279
– –
DVAX
35
DELISTED
Dynavax Technologies
DVAX
$12.1M 0.17%
794,747
+52,732
+7% +$912K
BSX icon
36
Boston Scientific
BSX
$68.4B
$12M 0.17%
367,194
– –
VTRS icon
37
Viatris
VTRS
$20.7B
$11.9M 0.17%
330,668
+53,642
+19% +$2.1M
CNC icon
38
Centene
CNC
$30.5B
$11.5M 0.16%
187,306
– –
VRTX icon
39
Vertex Pharmaceuticals
VRTX
$123B
$11M 0.15%
64,530
+16,134
+33% +$2.5M
CELG
40
DELISTED
Celgene Corp
CELG
$9.77M 0.14%
123,070
-1,400
-1% -$116K
INSM icon
41
Insmed
INSM
$22.5B
$9.72M 0.13%
410,954
+38,292
+10% +$986K
ALXN
42
DELISTED
Alexion Pharmaceuticals
ALXN
$9.38M 0.13%
75,574
– –
ESRX
43
DELISTED
Express Scripts Holding Company
ESRX
$9.23M 0.13%
119,604
– –
SRPT icon
44
Sarepta Therapeutics
SRPT
$1.64B
$9.18M 0.13%
69,427
+2,155
+3% +$203K
JAZZ icon
45
Jazz Pharmaceuticals
JAZZ
$16.1B
$8.54M 0.12%
49,592
– –
HRTX icon
46
Heron Therapeutics
HRTX
$94.1M
$8.2M 0.11%
211,012
+97,002
+85% +$3.09M
HCA icon
47
HCA Healthcare
HCA
$90.5B
$8.16M 0.11%
79,535
– –
LLY icon
48
Eli Lilly
LLY
$1.08T
$7.84M 0.11%
91,848
-33,272
-27% -$2.73M
DXCM icon
49
DexCom
DXCM
$29B
$7.66M 0.11%
322,412
+69,680
+28% +$1.48M
AERI
50
DELISTED
Aerie Pharmaceuticals
AERI
$7.49M 0.1%
110,838
+38,099
+52% +$2.13M
1
2
3 4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q2 2018 Portfolio in Review

As of Q2 2018, C WorldWide Group held 137 positions worth $7.21B, up 11% from $6.51B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

C WorldWide Group deployed $299M of net new capital in Q2 2018, opening 11 new positions and adding to 44 existing holdings. Its largest new stake was Procter & Gamble: 1,450,915 shares worth $113M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 30% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was TSMC, an estimated $77.1M trimmed.

  • C WorldWide Group's largest Q2 2018 buy was Procter & Gamble: 1,450,915 shares worth $113M.
  • C WorldWide Group added most to Coca-Cola in Q2 2018, an estimated $296M increase.
  • C WorldWide Group's biggest Q2 2018 reduction was TSMC, cutting an estimated $77.1M.
  • C WorldWide Group fully exited Almost Family Inc in Q2 2018, selling an estimated $1.68M.
  • C WorldWide Group's ten largest holdings make up 73% of its $7.21B portfolio in Q2 2018.
  • C WorldWide Group opened 11 new positions and closed 5 in Q2 2018.
  • C WorldWide Group's portfolio value rose 11% quarter-over-quarter to $7.21B.

Based on C WorldWide Group's 13F filing for Q2 2018, filed 3 Aug 2018.